Regarding Gal-3 and DKK-1, we showed that patients with higher disease activity exhibited elevated levels of Gal-3 and DKK-1, consistent with other studies that have shown correlations between these biomarkers and acute-phase reactants in RA patients [66,67]. This evidence concerns the gene DKK1 and rheumatoid arthritis.